Today: 23 March 2026
Subscribe
Browse Category

Stock Market 11 January 2026

Wave Life Sciences stock drops 7% into JPM Healthcare Conference week — what to know next

Wave Life Sciences stock drops 7% into JPM Healthcare Conference week — what to know next

Wave Life Sciences shares fell 6.7% to $13.84 Friday, underperforming biotech peers ahead of the J.P. Morgan Healthcare Conference. Investors are watching for CEO Paul Bolno’s Tuesday update on WVE-007, its obesity drug, after December’s interim data showed a 9.4% visceral fat reduction. The company recently raised $350 million in a public offering.
11 January 2026
··
Merit Medical stock slides 7% after board shake-up and early Q4 revenue range — what to watch next

Merit Medical stock slides 7% after board shake-up and early Q4 revenue range — what to watch next

Merit Medical shares fell 7.3% to $86.38 Friday after the company reported preliminary Q4 revenue of $389 million to $395 million and announced a board leadership change. Founder Fred Lampropoulos resigned as chair, replaced by F. Ann Millner. Lampropoulos will serve as a consultant for $250,000 per month. Full 2025 results and 2026 guidance are due Feb. 24.
11 January 2026
··
Century Communities stock jumps 11% on Trump mortgage-bond order — what to watch before Monday

Century Communities stock jumps 11% on Trump mortgage-bond order — what to watch before Monday

Century Communities shares jumped 10.7% to $68.33 Friday, their biggest gain in months, after President Trump announced $200 billion in mortgage bond purchases to lower housing costs. Homebuilder and mortgage stocks surged, while Fed officials questioned the plan’s impact on affordability. U.S. single-family housing starts rose 5.4% in October, but permits slipped 0.5%. The Consumer Price Index report is due Tuesday.
11 January 2026
··
Tri Pointe Homes stock jumps nearly 9% as mortgage-bond move lifts homebuilders; CPI is next

Tri Pointe Homes stock jumps nearly 9% as mortgage-bond move lifts homebuilders; CPI is next

Tri Pointe Homes shares surged 8.7% to $35.42 Friday after President Trump ordered $200 billion in mortgage-backed securities purchases to lower mortgage rates. Other homebuilder stocks also rallied. Freddie Mac reported the average 30-year fixed mortgage at 6.16% this week. Traders await Tuesday’s U.S. CPI report for the next move in rates.
11 January 2026
······
Lennar stock jumps nearly 9% on Trump’s $200 billion mortgage-bond push — what to watch next

Lennar stock jumps nearly 9% on Trump’s $200 billion mortgage-bond push — what to watch next

Lennar Corp surged 8.85% to $119.25 Friday, leading U.S. homebuilders higher after President Trump ordered $200 billion in mortgage bond purchases. Treasury Secretary Scott Bessent said the move aims to offset the Fed’s MBS roll-off. Analysts expect the plan to lower mortgage rates by 10–25 basis points. Wall Street questioned whether Fannie Mae and Freddie Mac will remain under government control.
11 January 2026
····
Fluence Energy (FLNC) stock jumps 9.5% — here’s what traders watch into Monday and CPI week

Fluence Energy (FLNC) stock jumps 9.5% — here’s what traders watch into Monday and CPI week

Fluence Energy shares closed up 9.5% at $23.20 Friday, then rose to $23.30 after hours as the S&P 500 hit a record. The move followed a weaker U.S. jobs report and persistent expectations for Fed rate cuts. Virginia lawmakers plan to revisit energy storage bills next week, with Fluence executives involved in discussions. U.S. December CPI data is due Jan. 13.
11 January 2026
·
Eos Energy (EOSE) stock jumps 9% — what investors watch before Monday’s open

Eos Energy (EOSE) stock jumps 9% — what investors watch before Monday’s open

Eos Energy shares jumped 9% to close at $15.28 Friday, with trading volume topping 23 million. Options activity stayed bullish as the put/call ratio dropped to 0.25 and implied volatility neared 96%. The company recently secured a $305 million federal loan guarantee to expand battery production in Pennsylvania. Investors await Eos’ next earnings report, expected in early March.
11 January 2026
··
Meritage Homes stock jumps 10% on Trump mortgage-bond order — what to watch next week

Meritage Homes stock jumps 10% on Trump mortgage-bond order — what to watch next week

Meritage Homes surged 10.4% to $75.45 after President Trump ordered $200 billion in mortgage bond purchases, aiming to lower rates. Fannie Mae and Freddie Mac will handle the buys, but details remain unclear. New housing data showed single-family starts up 5.4% in October, while permits dipped 0.5%. The Consumer Price Index for December is due Jan. 13.
11 January 2026
······
Bloom Energy stock jumps again after $2.65 billion AEP fuel-cell deal; what investors watch next

Bloom Energy stock jumps again after $2.65 billion AEP fuel-cell deal; what investors watch next

Bloom Energy shares closed up 10% at $134.07 on Friday after American Electric Power announced a $2.65 billion deal for Bloom’s fuel cells tied to a planned Wyoming plant. The stock held gains in after-hours trading as investors watched for further contract milestones. AEP’s 20-year offtake agreement for the plant’s output is contingent on conditions expected by Q2 2026. Bloom’s next earnings report is projected for February 26.
11 January 2026
···
CG Oncology stock jumps 29% on faster Phase 3 PIVOT-006 data clock — what to watch next

CG Oncology stock jumps 29% on faster Phase 3 PIVOT-006 data clock — what to watch next

CG Oncology shares jumped nearly 29% Friday, closing at $54.20, after the company said topline Phase 3 trial data for its bladder cancer therapy will arrive in the first half of 2026, almost a year early. Morgan Stanley raised its price target to $93, citing the accelerated timeline. The PIVOT-006 trial enrolled over 360 patients at more than 90 sites.
11 January 2026
··
Vistra stock pops on Meta nuclear contracts — what VST bulls and bears watch next week

Vistra stock pops on Meta nuclear contracts — what VST bulls and bears watch next week

Vistra Corp shares surged 10.5% to $166.37 after Meta signed 20-year deals to buy nuclear power from three Vistra plants. The contracts cover 2,609 MW from Ohio and Pennsylvania facilities, with full operating delivery by 2027 and uprates by 2034. Fitch raised Vistra’s outlook to positive. Vistra also agreed to buy Cogentrix Energy for $4.7 billion, adding 10 gas plants.
11 January 2026
··
Revolution Medicines stock in focus as Merck buyout talk hangs over RVMD into JPMorgan week

Revolution Medicines stock in focus as Merck buyout talk hangs over RVMD into JPMorgan week

Revolution Medicines shares jumped 10.7% to $118.64 Friday amid reports Merck is in talks to acquire the company for up to $32 billion, according to the Financial Times. Trading volume hit 20.8 million shares. AbbVie denied it was in discussions after an earlier report, sending Revolution’s stock down 11.5% after hours. The FDA granted Breakthrough Therapy status to Revolution’s lung cancer drug candidate.
11 January 2026
··
1 … 554 555 556 557 558 … 1,359

Stock Market Today

  • Australia Shares Expected to Decline at Open, New Zealand Markets Fall
    March 22, 2026, 6:45 PM EDT. Australian shares are forecast to open lower amid regional market pressures, with New Zealand's market also declining. Investors remain cautious as global economic indicators weigh on sentiment. The Australian Securities Exchange (ASX) is set to follow the downtrend seen in other Asia-Pacific markets, reflecting concerns over growth prospects. New Zealand's benchmark index has retreated, pressured by similar factors. Traders are monitoring external influences, including commodity prices and currency fluctuations, ahead of key economic data releases. The outlook remains uncertain as markets adjust to ongoing geopolitical and economic developments.
Go toTop